Accelerating Cell & Gene Therapeutic Success Through Healthcare, Government and Patient Buy-In

06 Sep 2023
11:00

 

11:00am Chair Introduction 

Vasiliki Kalodimou, Director of Flow Cytometry Research and Regenerative Medicine, IASO  

 

11:05am Presentation: Title to be Confirmed 

  • Presentation content to be added

Lucy Ellerker Jones, Founder, Opie Foundation 

  

11:20am Presentation: Title to be Confirmed 

  • Presentation content to be added

Julia Djonova, Head of the Advanced Therapy Medicinal Products, Swissmedic 

  

11:35am Presentation: Title to be Confirmed 

  • Characteristics of Gene Therapies and the European access environment  
  • Impact of the EU pharmaceutical legislative review on the ATMP Sector 

Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA, PTC Therapeutics   

  

11:50am Presentation: Title to be Confirmed 

  • Presented content to be added

Simon Jones, Medical Director, NIHR Clinical Research Facility, NIHR (National Institute of Health Research) 

  

12:05pm Closing Panel with Q&A 

With all session participants 

 

 

Speakers

Vasiliki Kalodimou
Director of Flow Cytometry Research and Regenerative Medicine
Iaso
Julia Djonova
Head of the Advanced Therapy Medicinal Products
Swissmedic
Thomas Bols
Head of Government Affairs and Patient Advocacy, EMEA
PTC Therapeutics
Simon Jones
Medical Director, NIHR Clinical Research Facility
NIHR (National Institute for Health Research)